While MALAT1 has been reported to be overexpressed in gliomas and associated with pathogenesis and chemoresistance [60], the specific molecular mechanism by which MALAT1 influences AS of its targets in gliomas, has yet to be determined. Here, MALAT1 is linked to central nervous system cancer.